MICROBIAL PERSISTENCE
Open accessThe DOI matches its Crossref record.
Abstract
The capability of tubercle bacilli to assume a long continued sterile state in the tissues when exposed to pyrazinamide and isoniazid is a highly specific drug-microbe phenomenon in which host participation is not critical. Although it is the pyrazinamide that possesses the sterilizing type of action, the role of the isoniazid is specific and essential. The isoniazid serves to convert a phenomenon that occurs irregularly with pyrazinamide alone into one that occurs with a high degree of uniformity. The observations suggest a competition between isoniazid and the pyrazinamide (or its parent nicotinamide) for a site or entrance in or on the tubercle bacilli and for sterilization, the isoniazid apparently must reach the site first. The rare failures to attain complete sterilization, appear to depend on the emergence of pyrazinamide-resistance which prevents the necessary dependent action of the two drugs. Populations already in the sterile state are nevertheless subject to a continued drug influence. Whether this represents a direct action on the sterile bacilli or an indirect effect produced by making the environment hostile to microbial revival, cannot be determined from the present observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Park, H., Guinn, K. M., Harrell, M. I., Liao, R., Voskuil, M. I., Tompa, M., Schoolnik, G. K., & Sherman, D. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03474.x · Cited by 712
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Tuberculosis: Latency and Reactivation
Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4195-4201.2001 · Cited by 500
Mechanisms of latency in Mycobacterium tuberculosis
Parrish, N. M., Dick, J. D., & Bishai, W. R. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01216-5 · Cited by 483
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 413
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response
Grant, S. S., & Hung, D. T. (2013) · Virulence · doi:10.4161/viru.23987 · Cited by 363
Vaccines and cell-mediated immunity
Collins, F. M. (1974) · Bacteriological Reviews · doi:10.1128/br.38.4.371-402.1974 · Cited by 350
Mechanisms of Pyrazinamide Action and Resistance
Zhang, Y., Shi, W., Zhang, W., & Mitchison, D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0023-2013 · Cited by 332
Yuan, Y., Crane, D. D., Simpson, R. M., Zhu, Y., Hickey, M. J., Sherman, D. R., & Barry, C. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9578 · Cited by 314
McCune, R. M., Feldmann, F. M., Lambert, H. P., & McDermott, W. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.3.445 · Cited by 310
Self-citationBasic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
Latent Mycobacterium tuberculosis–persistence, patience and winning by waiting
Manabe, Y. C., & Bishai, W. R. (2000) · Nature Medicine · doi:10.1038/82139 · Cited by 275
Targeting Persisters for Tuberculosis Control
Zhang, Y., Yew, W. W., & Barer, M. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06288-11 · Cited by 271
Radaeva, T. V., Nikonenko, B. V., Mischenko, V. V., Averbakh, M. M., & Apt, A. S. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.09.014 · Cited by 36
Are all antibiotic persisters created equal?
Shultis, M. W., Mulholland, C. V., & Berney, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933458 · Cited by 19
Metadata
- Authors
- McCune, R. M., Feldmann, F. M., & McDermott, W.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1966-03-01
- Volume
- 123
- Issue
- 3
- Pages
- 469-486
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2015452345
- Cited by
- 156
- References
- 0
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.